CRL
Charles River Laboratories International Inc
$158.93
+1.86% (+$2.90)
Volume
867,752
52W High
$228.88
52W Low
$132.58
Market Cap
$8.97B
Next Earnings Report
Last Reported
May 7, 2026 Beat
Actual: $2.06
vs. Consensus: $1.93
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q1 2026
May 7, 2026
1-Day:
-2.23%
5-Day:
-7.15%
Q1 2026
May 6, 2026
1-Day:
-0.03%
5-Day:
-7.30%
Q4 2025
Feb 18, 2026
1-Day:
+3.95%
5-Day:
+3.49%
Q3 2025
Nov 5, 2025
1-Day:
+1.90%
5-Day:
+0.76%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $994.2M | -0.8% | 31.0% | 12.1% | -$276.6M |
| Q3'25 | $1.00B | -0.5% | 33.7% | 13.3% | $54.4M |
| Q2'25 | $1.03B | +0.6% | 34.6% | 9.7% | $52.3M |
| Q1'25 | $984.2M | -2.7% | 32.3% | 7.6% | $25.5M |
| Q4'24 | $1.00B | -1.1% | 28.4% | -16.7% | -$215.7M |
| Q3'24 | $1.01B | -1.6% | 34.6% | 11.6% | $68.7M |
| Q2'24 | $1.03B | -3.2% | 34.5% | 14.8% | $90.0M |
| Q1'24 | $1.01B | -1.7% | 34.1% | 12.5% | $67.3M |
Company Information
Symbol
CRL
Company
Charles River Laboratories International Inc
Market Cap
$8.97B